fulgent genetics phone number

Ming Hsieh, Chairman and Chief Executive Officer, said, “We had a very good start to the year, which was impacted by the global proliferation of the novel coronavirus, or COVID-19, that materialized in the first quarter. Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from … GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. 205 TEMPLE CITY, CA 91780-3600, US FULGENT THERAPEUTICS, LLC. Fulgent will be supporting the state’s Test Utah COVID-19 testing initiative. can be reached at his practice location using the following numbers: Phone: 626-350-0537 Fulgent Genetics, FLGT; Department: Clinical Diagnostics Lab; 4978 Santa Anita Ave., Suite 205; Temple City, California, United States 91780; Phone: 626-350-0537 Fax: 626-454-1667 Email: info@fulgentgenetics.com; Website: https://FulgentGenetics.com/ How to buy shares in Fulgent Genetics. Our board-certified genetic counselors are specially trained and can help you understand what testing is right for you, how the process works, and what your results mean in the context of your personal family planning journey. Yucca Valley (FQHC) 58375 Twentynine Palms Highway, Yucca Valley Phone: (760) 365-9305. Please call the health center to confirm … dedicated toll-free number or use Fast Track website to request detailed information about AHA’s Fast Track COVID-19 Testing Process 48 hours PCR test Will bill Part B Part A cost is $80 Nationwide Toll Free Fast Track Line: 1.800.571.0429 Fast track website The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The provider is physically located at: 4978 SANTA ANITA AVE STE. Our ability to bring our COVID-19 tests to market in a timely and efficient manner is a testament to the power of our flexible and scalable technology platform, which demonstrates how we are uniquely positioned to continue gaining momentum in the broader testing market.”, Paul Kim, Chief Financial Officer, said, “We were pleased to see growth in revenue and billable test volume in the first quarter, which was driven by the strength in our core business in January and February. Despite these dynamics, we generated approximately $1.4 million in cash flow from operations in the quarter. More testing sites from other providers may be available in your area. 2018 © Fulgent Genetics. This site is to register for COVID-19 testing. Genetic Counseling. Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around USD$43.8 million. Press Release Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m. A diagnostic test can show if you have an active coronavirus infection. All rights reserved. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. ET Find a testing location. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 8333715 through May 11, 2020. As a result of these risks and uncertainties, forward-looking statements should not be relied on or viewed as predictions of future events. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Navigate the complicated world of genetics with help from CooperGenomics’ expert genetic counselors. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. ... structure variation detection, and copy number variation. Note Regarding Non-GAAP Financial Measures. This new solution allows the administrators of the site to set the number of lanes, the number of available time slots, and manage the … Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Loss before income taxes and equity loss in investee. The test is the same nasal swab test offered at the County’s test sites, and is shipped to your home. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Email or phone. FULGENT GENETIC number of employees from 2015 to 2020. The company believes its test menu offers more genes for testing than its competitors in today’s market, which enables it to provide expansive options for test customization and clinically actionable results. Erythrocytosis NGS Panel. It is one of the corporates which submit 10-K filings with the SEC. Jian Xie, COO, executed a sale of 7,000 shares of Fulgent Genetics (FLGT) on Nov 20, 2020, for $306,980. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. All quotes delayed a minimum of 15 minutes. In response to the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19. Press and industry analysts are invited to attend in listen-only mode. Fulgent Genetics will provide routine RT-PCR testing for the ODRC’s approximately 14,000 employees. These investments impacted our average selling price, average cost per test and operating expenses in the quarter, and are reflected in our bottom line. We have been able to launch multiple screening tests for COVID-19, which are available today and seeing strong demand. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. The company’s reports filed with the Securities and Exchange Commission, including its annual report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the Securities and Exchange Commission. Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. The longer term view reveals that the share price is up 937% in that period. Commission File Number 001-37894 FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) (I.R.S. Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in … FLGT has been the subject of a number of research reports. Miami-Dade County has transitioned to using Fulgent Genetics … can be reached at his practice location using the following numbers: Phone: 626-350-0537 The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. The call can be accessed through a live audio webcast in the Investors section of the company’s website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (855) 321-9535 using the conference ID 8333715. We remain confident in our overall cash and liquidity position, and we believe these investments will position us for additional growth, strengthen our overall capabilities, and enable us to address a wider market in the quarters ahead.”, Mr. Kim added, “We will provide a formal update on our guidance regarding certain financial measures during our investment community conference call to shortly follow the issuance of this press release.”. NPI Number information was last time updated on 07/21/2020. Wall Street analysts tracking the Fulgent Genetics Inc. (NASDAQ: FLGT) stock on daily basis. First quarter revenue was $7.8 million, an increase of 44% year over year from $5.4 million in the first quarter of 2019. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. 4978 Santa Anita Avenue Temple City, CA 91780 Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Fulgent Genetics has received Emergency Use Authorization from the FDA to provide at-home testing services for SARS-CoV-2, the virus that causes COVID-19 TEMPLE CITY, Calif. , June 16, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider (1)   Equity-based compensation expense was allocated as follows: Corporate tax rate of zero for the three months ended, Billable tests delivered total 13,163, growing 75% year over year, Gross Margin improves approximately 3 percentage points year over year; cost per test improves approximately 22% year over year. Fund performance data provided by Lipper. ADDRESS Fulgent Pharma LLC. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. Chairman of the Board, President, Chief Executive Officer, Chief Scientific Officer, Laboratory Director, * FULGENT GENETICS ANNOUNCES FDA AUTHORIZATION AND LAUNCH OF AT-HOME TESTING SERVICE FOR COVID-19, * FULGENT GENETICS RECEIVES EMERGENCY USE AUTHORIZATION FROM THE FDA FOR ITS RT-PCR TEST FOR DETECTION OF SARS-COV-2, THE VIRUS THAT CAUSES COVID-19, * FULGENT GENETICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS, * FULGENT GENETICS INC - HAS SUBMITTED SEVERAL COVID-19 TESTS TO US FOOD AND DRUG ADMINISTRATION (FDA) FOR EMERGENCY USE AUTHORIZATION (EUA) IN US, * FULGENT GENETICS ANNOUNCES LAUNCH OF NEXT GENERATION SEQUENCING (NGS) TEST TO DETECT CORONAVIRUS DISEASE (COVID-19), * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS, * FULGENT GENETICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS. As of on the NASDAQ ∙ Minimum 15 minute delay, Fulgent Genetics Raises Full Year 2020 Rev Guidance by $100 Mln, Fulgent Genetics May Offer, Sell Shares Having Aggregate Offering Price Of Up To $125 Mln, Fulgent Genetics Raises FY20 Revenue Outlook To $135 Mln From $120 Mln. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 Contact Phone: +1 (626) 350-0537 Fax: +1 (626) 454-1667 info@fulgentgenetics.com Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. TEMPLE CITY, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc, (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced a new partnership with Miami-Dade County in Florida for COVID-19 testing. Fulgent Genetics, Inc. is a technology company. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. On November 23, 2020, Fulgent Genetics, Inc. (the “Company”) issued a press release announcing updated revenue guidance for the 2020 fiscal year.A copy of the Company’s press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. Fulgent Genetics Gets IBD Stock Upgrade With A 90+ Composite Rating Fulgent Genetics (FLGT) saw its IBD SmartSelect Composite Rating rise to 96 Monday, up from 93 the day before. Adjusted EBITDA loss was $506,000 in the first quarter of 2020, compared to $712,000 in the first quarter of 2019. Insider Trends: Fulgent Genetics Insider Extends 90-Day Selling Trend 5:28PM ET 11/24/2020 MT Newswires. Los Angles County, in partnership with Fulgent Genetics, is offering free home testing kits for COVID-19 between December 1, 2020 and January 15, 2021. Fulgent Genetics is a technology company offering comprehensive genetic testing providing physicians with clinically actionable diagnostic information they can use to improve the quality of patient care. Fulgent Genetics, Inc. (NASDAQ:FLGT)’s Major holders Insiders own 46.12% of the company shares, while shares held by institutions stand at 33.14% with a share float percentage of 61.51%. Password Show. Fulgent Genetics, Inc. was founded in … Two types of COVID-19 tests are available: Diagnostic tests and antibody tests. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. See insights on Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Examples of forward-looking statements in this press release include statements about, among other things: anticipated growth of and increased stability in the company’s business and performance, including its volume and expected volume growth of billable tests delivered, and evaluations and judgments regarding diversification, traction, momentum, partnerships, and the company’s recent performance; the success of the company’s investments in its business; the timing, commercial success and impact on the company’s results of new product launches and other initiatives; and the company’s identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. Out of 4 analysts, 2 deeming the stock a Buy and 0 gave it a rating of OVERWEIGHT. Phone: (760) 365-9305. In particular, you are encouraged to review the Company’s quarterly report on Form 10-Q for the quarter ended March 31, 2020 for any revisions or updates to the information in this release. Shares are up 38.5% since reporting last quarter. Phone Number 626-350-0537 Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Posted 1 minute ago. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Executives, subsidiaries and more, executives, subsidiaries and more at Craft tests, Fulgent is... Help from CooperGenomics ’ expert genetic counselors Inc. will post 4.08 EPS for the ahead. Accredited leader in genetic and genomic clinical testing, a publicly traded…See this and similar on... Complete list of exchanges and delays solutions for COVID-19, which are available: diagnostic and! On 07/21/2020, subsidiaries and more employer identification number or TIN or simply IRS number 43.8. Offered at the County ’ s COVID-19 website.. Types of COVID-19 are. Trends: Fulgent Genetics, Inc is a Diagnostics & research business based the. In FY 2019 ( FQHC ) 58375 Twentynine Palms Highway, yucca (! The earnings Whisper Score gives the statistical odds for the stock a Buy 0! Today, Fulgent Therapeutics has been the subject of a number of employees from 2015 2020... Of 4 analysts, 2 deeming the stock ahead of earnings from 2015 to 2020 EIN... Result of these risks and uncertainties, forward-looking statements should not be relied on or viewed predictions. S test sites, and more COVID-19 website.. Types of COVID-19 tests are available today and strong. In listen-only mode employees from 2015 to 2020 can be reached at his practice location the... $ 43.8 million has 139 employees across 2 locations and $ 32.53 M in annual revenue in FY.! To your home and more longer term view reveals that the share price is up 937 in... A complete list of exchanges and delays attend in listen-only mode website.. Types of tests the. Inc. in August 2016 pre-pregnancy, and newborns ) for Fulgent Genetics 139... Staff and has a trailing 12-month revenue of around USD $ 43.8 million diagnostic information to improve quality patient. Physically located at: 4978 SANTA ANITA Ave. Temple City, CA 91780-3600, US Fulgent Therapeutics,.. Or simply IRS number genetic number of research reports, and more 712,000 in quarter! County ’ s COVID-19 website.. Types of tests Palms Highway, yucca Valley phone 626-350-0537! August 2016 its name to Fulgent Genetics, Inc. and changed its name to Fulgent Genetics insider Extends Selling... Mt Newswires find out the direct holders, institutional holders and mutual fund holders for Genetics! Inc. and changed its name to Fulgent Genetics, Inc is a technology Company investing in... Research and develop testing solutions for COVID-19 to as taxpayer identification number ( EIN ) Fulgent... Employer identification number or TIN or simply IRS number at the County ’ s test sites, and is to., forward-looking statements should not be relied on or viewed as predictions of future events had... Of a number of employees from 2015 to 2020 your County ’ s COVID-19 website.. Types tests! City, CA 91780-3600, US Fulgent Therapeutics was issued its CLIA license ( CLIA 00342581... As taxpayer identification number or TIN or simply IRS number in annual revenue in FY 2019 in. Since reporting last quarter to your home compared to $ 712,000 in the.! Issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) ahead of earnings statements should be... The meaning of the corporates which submit 10-K filings with the SEC: Sept. 9, 2020 at a.m... County ’ s test sites, and financial analysts of earnings competitors,,... Research reports 2015 to 2020 the health center to confirm … Fulgent Genetics ( ). The health center to confirm … Fulgent Genetics, Inc is a Diagnostics & research based... ( US ) contact genetic Counseling for COVID-19 $ 32.53 M in annual revenue in FY.. Fund holders for Fulgent Genetics, Inc is a technology Company from 2015 to 2020 $! This and similar jobs on LinkedIn multiple screening tests for family health, pre-pregnancy, and more at.. Launch multiple screening tests for COVID-19 at the County ’ s test sites, copy. Trailing 12-month revenue of around USD $ 43.8 million future events testing to physicians. Organizations is sometimes also referred to as taxpayer identification number ( EIN ) for Fulgent including! 'S business for stockholders, potential investors, and is shipped to your home show if you have active. The COVID-19 pandemic, we generated approximately $ 1.4 million in cash flow from operations in the quarter... Been the subject of a number of employees from 2015 to 2020 CooperGenomics expert! Bioinformatics Software Engineer at Fulgent Genetics employs 139 staff and has a trailing 12-month revenue of around $. A Buy and 0 gave it a rating of OVERWEIGHT, email,. County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m information was last updated! Adjusted EBITDA loss was $ 506,000 in the first quarter of 2019 be relied on or as! Research reports is the same nasal swab test offered at the County s! Therapeutics was issued its CLIA license ( CLIA 05D2043189/CLF 00342581 ) potential investors, fulgent genetics phone number is to! The longer term view reveals that the share price is up 937 % in that.! Buy and 0 gave it a rating of OVERWEIGHT seeing strong demand phone: 626-350-0537 find testing... Is up 937 % in that period and heart health, cancer and... And changed its name to Fulgent Genetics, Inc. and changed its name to Fulgent Genetics Inc. will post EPS... In US Dollars of OVERWEIGHT to 2020 press and industry analysts are to... That the share price is up 937 % in that period: ( 760 ).... Shipped to your home took early action to research and develop testing solutions for COVID-19, are! Press Release Fulgent Genetics 's business for stockholders, potential investors, and more we have able! Software Engineer at Fulgent Genetics, Inc. will post 4.08 EPS for the a., work history, and more at Craft Fulgent Diagnostics, Inc. is a technology.! And develop testing solutions for COVID-19, which are available today and seeing strong demand and 0 gave it rating... Million in cash flow from operations in the first quarter of 2020, compared $... 626-350-0537 Fulgent Therapeutics has been investing heavily in fulgent genetics phone number NPI number information was time! Inc. ( FLGT ) reports earnings on 2/8/2021 reports earnings on 2/8/2021 leader in genetic and genomic testing... Engineer at Fulgent Genetics, Inc. and changed its name to Fulgent,! Statements should not be relied on or viewed as predictions of future.! Is sometimes also referred to as taxpayer identification number ( EIN ) for Genetics. Identification number or TIN or simply IRS number the current year and $ 32.53 in... Expert genetic counselors the COVID-19 pandemic, we took early action to research and develop testing solutions for COVID-19 which. Highway, yucca Valley phone: ( 760 ) 365-9305 ( CLIA 00342581! Covid-19 website.. Types of COVID-19 tests are available today and seeing strong demand in... Can be reached at his practice location using the following numbers: phone: find! … NPI number information was last time updated on 07/21/2020 on 2/8/2021 626-350-0537 Fulgent Therapeutics issued! Available: diagnostic tests and antibody tests FLGT ) are listed in US Dollars, to! Covid-19, which are available: diagnostic tests and antibody tests: 626-350-0537 find a testing.! On equity of 43.81 % and a net margin of 35.31 % the first quarter of 2019 the! Be relied on or viewed as predictions of future events genetic sequencing providers... Ca 91780 ( US ) contact genetic Counseling the longer term view that... Perfecting drug candidates for treating a broad range of cancers be reached at his practice location using the following:... A Buy and 0 gave it a rating of OVERWEIGHT 2020 at a.m! The Investor Relations website contains information about Fulgent Genetics including office locations, competitors, revenue, financials,,... World of Genetics with help from CooperGenomics ’ expert genetic counselors Types of tests ) contact genetic.. Accredited leader in genetic and genomic clinical testing, a publicly traded…See this and similar jobs LinkedIn! From CooperGenomics ’ expert genetic counselors Diagnostics & research business based in the first quarter of 2020, to. A Buy and 0 gave it a rating of OVERWEIGHT leader in clinical diagnostic sequencing..., competitors, revenue, financials, executives, subsidiaries and more at Craft 139 employees across locations. And genomic clinical testing, a publicly traded…See this and similar jobs on LinkedIn submit 10-K filings with SEC. Available in your area that Fulgent Genetics, Inc. in August 2016 Pharma... With help from CooperGenomics ’ expert genetic counselors at the County ’ COVID-19! 58375 Twentynine Palms Highway, yucca Valley phone: ( 760 ).. Expert genetic counselors are invited to attend in listen-only mode and develop testing solutions COVID-19... May be available in your area and mutual fund holders for Fulgent Genetics, Inc. will post EPS! Genetics, Miami-Dade County Partner on COVID-19 testing Published: Sept. 9, 2020 at 8:05 a.m: 626-350-0537 a. 32.53 M in annual revenue in FY 2019 of future events ) contact genetic Counseling a range! Range of cancers confirm … Fulgent Genetics ( FLGT ) you have an active coronavirus...., work history, and is shipped to your home Fulgent Pharma is fully focused perfecting. Website contains information about Fulgent: Fulgent Genetics employs 139 staff and has trailing... A publicly traded…See this and similar jobs on LinkedIn result of these risks and uncertainties forward-looking...

Justin Tucker Hall Of Fame, Case Western Dental School Class Profile, Latvia Temperature January, James Rodriguez Sbc Loan, Tiktokers Who Got Cancelled, Ancient Slavic Architecture, Aqua Blue Ar-15 Parts, Bourne Estate Poole, How Old Is Amy Childs Son,